论文部分内容阅读
冬虫夏草历来是一味名贵的中药材。野生产量极为稀少。随着医疗保健事业的发展,国内外市场需要量急增,因而成为一味严重紧缺药材。为了满足冬虫夏草的药用需要,浙江省科委下达了“虫草头孢菌丝体深层发酵与药用研究”课题,于83年8月至85年4月由浙江省中药研究所和杭州第二中药厂共同承担完成,他们所分离得到的虫草菌种经中国科学院微生物所真菌分类专家鉴定为虫草头孢,是国内发现的新种。
Cordyceps has always been a rare Chinese herbal medicine. Wild production is extremely rare. With the development of the healthcare industry, the demand in domestic and foreign markets has increased rapidly, and it has become a serious shortage of medicinal herbs. In order to meet the medicinal needs of Cordyceps sinensis, the Zhejiang Provincial Committee of Science and Technology issued the topic of “Deep fermentation and medicinal use of Cordyceps cephalosporin mycelia.” From August 83 to April of the year, the Zhejiang Institute of Chinese Materia Medica and the Second Chinese Medicine of Hangzhou The plant shared the responsibility and the strains of Cordyceps sinensis isolated from them were identified as cephalosporins of Cordyceps sinensis by experts in the classification of fungi of the Institute of Microbiology, Chinese Academy of Sciences. They are new species discovered in China.